Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab (Q36986787)
Jump to navigation
Jump to search
scientific article published on 27 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab |
scientific article published on 27 June 2008 |
Statements
1 reference
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab (English)
1 reference
Tait D Shanafelt
1 reference
Timothy G Call
1 reference
Clive S Zent
1 reference
Diane F Jelinek
1 reference
Neil E Kay
1 reference
Charla R Secreto
1 reference
Renee C Tschumper
1 reference
Betsy R LaPlant
1 reference
Nancy D Bone
1 reference
27 June 2008
1 reference
1 reference
1849-1856
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference